Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Emerging Therapy
Page 21
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Aquestive Works with FDA to Resolve Hurdles for its New Sublingual Epinephrine Candidate
Dave Bloom
-
2026/01/09
Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025
Very Low-Dose Multi-Nut OIT Promising for Children with Multiple Food Allergies
DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals in Phase 3 Trial
Mabylon Begins Human Clinical Trials of New Peanut Allergy Treatment
AAAAI Addresses What Patients and Their Families Need to Know About...
News Wire ~ 3rd Party Press Release
-
2019/09/17
0
FAQ for Palforzia, the First FDA Approved Therapy for Food Allergy
Dave Bloom
-
2019/09/15
0
New Peanut Allergy Treatment Passes Phase 2 Trial, Shows Effectiveness and...
News Wire ~ 3rd Party Press Release
-
2019/09/05
0
Recruitment of Infants Begins for Phase 3 Trial of Cream to...
News Wire ~ 3rd Party Press Release
-
2019/08/22
0
Aimmune Enrolls First Patient in Phase 2 Trial of AR201 for...
News Wire ~ 3rd Party Press Release
-
2019/08/21
0
FDA to Hold Open Advisory Meeting on AR101 Peanut Allergy OIT...
Dave Bloom
-
2019/08/19
0
DBV Technologies Submits Biologics License Application to FDA for Viaskin Peanut...
News Wire ~ 3rd Party Press Release
-
2019/08/08
0
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple...
News Wire ~ 3rd Party Press Release
-
2019/08/01
0
Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food...
News Wire ~ 3rd Party Press Release
-
2019/07/02
0
Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...
News Wire ~ 3rd Party Press Release
-
2019/06/05
0
1
...
20
21
22
...
31
Page 21 of 31